Risk and management of adverse events in minimally invasive esophagectomy

Abstract

Minimally invasive esophagectomy (MIE) has transformed esophageal surgery by reducing morbidity, accelerating recovery, and improving postoperative outcomes compared to traditional open esophagectomy. By utilizing techniques such as laparoscopic, thoracoscopic, and robotic-assisted approaches, MIE minimizes surgical trauma while maintaining oncological thoroughness. However, it also presents unique challenges, including risks of complications such as anastomotic leakage, pulmonary complications, and atrial fibrillation. Zhong et al developed and validated a risk stratification model for predicting surgical adverse events after MIE, enhancing preoperative assessment and patient management. This editorial further examines the advantages of MIE, its comparable oncological and long-term outcomes, as well as the incidence and contributing factors of postoperative complications. Emerging technologies, including machine learning models, intraoperative nerve monitoring, and robotic-assisted surgery, are highlighted as innovative solutions for risk prediction and prevention. Strategies such as enhanced recovery after surgery protocols and multidisciplinary collaboration are emphasized for their critical roles in minimizing complications and optimizing patient outcomes. By addressing these aspects, this editorial provides guidance to surgical teams in maximizing the benefits of MIE while effectively managing its associated risks.

Keywords: Anastomotic leakage; Enhanced recovery after surgery; Minimally invasive esophagectomy; Robotic-assisted surgery; Surgical adverse events.